Article Reprint
Sustained Release Options for Glaucoma Therapeutics
This article summarizes how VitalDose® EVA drug delivery platform can help overcome the challenges of current therapies in the treatment of glaucoma. In addition, it proposes how existing glaucoma treatment devices can be made more effective by pairing them with a sustained-drug delivery mechanism.
Read the article today!
